The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
Open accessAbstract
Interleukin-18 (IL-18) is a potent pro-inflammatory cytokine involved in host defense against infections and regulates the innate and acquired immune response. IL-18 is produced by both hematopoietic and non-hematopoietic cells, including monocytes, macrophages, keratinocytes and mesenchymal cell. IL-18 could potentially induce inflammatory and cytotoxic immune cell activities leading to autoimmunity. Its elevated levels have been reported in the blood of patients with some immune-related diseases, including rheumatoid arthritis, systemic lupus erythematosus, type I diabetes mellitus, atopic dermatitis, psoriasis, and inflammatory bowel disease. In the present review, we aimed to summarize the biological properties of IL-18 and its pathological role in different autoimmune diseases. We also reported some monoclonal antibodies and drugs targeting IL-18. Most of these monoclonal antibodies and drugs have only produced partial effectiveness or complete ineffectiveness in vitro,in vivo and human studies. The ineffectiveness of these drugs targeting IL-18 may be largely due to the loophole caused by the involvement of other cytokines and proteins in the signaling pathway of many inflammatory diseases besides the involvement of IL-18. Combination drug therapies, that focus on IL-18 inhibition, in addition to other cytokines, are highly recommended to be considered as an important area of research that needs to be explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–207 of 207
Cancer‐killing, decoy‐resistant interleukin‐18
Nakamura, K., Bald, T., & Smyth, M. J. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12359 · Cited by 11
Kim, J., Jang, M. J., Jin, D.-H., Chung, Y. H., Choi, B., Park, G. B., Kim, Y. S., Kim, S., Hur, D. Y., Hung, C., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2308 · Cited by 9
Osman, A. E., Brema, I. A., AlQurashi, A., AlJurayyan, A. N., BRADLEY, B. A., & Hamza, M. A. (2021) · International Journal of Immunogenetics · doi:10.1111/iji.12535 · Cited by 7
Çelik, F., Çöteli, E., Gül, F. C., Özsoy, E., Kobat, S. G., Karagöz, Z. K., Aydın, S., Uğur, K., Yardım, M., Şahin, İ., et al. (2022) · International Ophthalmology · doi:10.1007/s10792-022-02331-4 · Cited by 7
Li, J., Wu, S., Wang, M.-R., WANG, T.-T., LI, B.-K., & Zhu, J. (2013) · Biomedical Reports · doi:10.3892/br.2013.186 · Cited by 6
Interleukin 18 and sICAM-1 serum levels in families with type 1 diabetes mellitus.
Mirończuk, K., Okruszko, A., Wawrusiewicz‐Kurylonek, N., Kretowski, A. J., Kinalska, I., & Górska, M. (2005) · PubMed · Cited by 6
Inflammatory mediators in polycystic ovary syndrome: the case of interleukin-18
Spritzer, P. M. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000455 · Cited by 4
Cited by
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
Al-Qahtani, A. A., Alhamlan, F. S., & Al-Qahtani, A. A. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9010013 · Cited by 291
Metadata
- Authors
- Ihim, S. A., Abubakar, S. D., Zian, Z., Sasaki, T., Saffarioun, M., Maleknia, S., & Azizi, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-08-11
- Volume
- 13
- Pages
- 919973-919973
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W4291018370
- Cited by
- 378
- References
- 207
- FWCI
- 26.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.